Clinical biomarkers in sepsis

Frontiers in Bioscience - Elite

Volumn 2 E, Issue 2, 2010, Pages 504-520

  Anderson, Rudolf ^a   Schmidt, Rene ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Biomarkers; C reactive protein; Interleukin 6; Lipopolysaccharide binding protein; Multi Organ failure; Procalcitonin; Review; Sepsis; SIRS; Systemic inflammation

Indexed keywords

EID: 84883306687     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Review

References (172)

1. G. S. Martin, D. M. Mannino, S. Eaton and M. Moss: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16), 1546-1554 (2003) (Pubitemid 36437931)
2. C. M. Martin, F. Priestap, H. Fisher, R. A. Fowler, D. K. Heyland, S. P. Keenan, C. J. Longo, T. Morrison, D. Bentley and N. Antman: A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Crit Care Med 37(1), 81-88 (2009)
3. C. Engel, F. M. Brunkhorst, H. G. Bone, R. Brunkhorst, H. Gerlach, S. Grond, M. Gruendling, G. Huhle, U. Jaschinski, S. John, K. Mayer, M. Oppert, D. Olthoff, M. Quintel, M. Ragaller, R. Rossaint, F. Stuber, N. Weiler, T. Welte, H. Bogatsch, C. Hartog, M. Loeffler and K. Reinhart: Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33(4), 606-618 (2007) (Pubitemid 46474888)
4. D. C. Angus, W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo and M. R. Pinsky: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7), 1303-1310 (2001) (Pubitemid 32641789)
5. E. Slade, P. S. Tamber and J. L. Vincent: The Surviving Sepsis Campaign: raising awareness to reduce mortality. Crit Care 7(1), 1-2 (2003) (Pubitemid 36204256)
6. G. Friedman, E. Silva and J. L. Vincent: Has the mortality of septic shock changed with time. Crit Care Med 26(12), 2078-2086 (1998) (Pubitemid 29016694)
7. C. L. Sprung, D. Annane, D. Keh, R. Moreno, M. Singer, K. Freivogel, Y. G. Weiss, J. Benbenishty, A. Kalenka, H. Forst, P. F. Laterre, K. Reinhart, B. H. Cuthbertson, D. Payen and J. Briegel: Hydrocortisone therapy for patients with septic shock. N Engl J Med 358(2), 111-124 (2008)
8. J. L. Vincent, Y. Sakr, C. L. Sprung, V. M. Ranieri, K. Reinhart, H. Gerlach, R. Moreno, J. Carlet, J. R. Le Gall and D. Payen: Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34(2), 344-353 (2006) (Pubitemid 43145611)
9. A. Kumar, D. Roberts, K. E. Wood, B. Light, J. E. Parrillo, S. Sharma, R. Suppes, D. Feinstein, S. Zanotti, L. Taiberg, D. Gurka and M. Cheang: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34(6), 1589-1596 (2006) (Pubitemid 43810035)
10. H. B. Nguyen, S. W. Corbett, R. Steele, J. Banta, R. T. Clark, S. R. Hayes, J. Edwards, T. W. Cho and W. A. Wittlake: Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 35(4), 1105-1112 (2007) (Pubitemid 46598962)
11. E. Rivers, B. Nguyen, S. Havstad, J. Ressler, A. Muzzin, B. Knoblich, E. Peterson and M. Tomlanovich: Early goaldirected therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19), 1368-1377 (2001)
12. E. M. Antman, M. Hand, P. W. Armstrong, E. R. Bates, L. A. Green, L. K. Halasyamani, J. S. Hochman, H. M. Krumholz, G. A. Lamas, C. J. Mullany, D. L. Pearle, M. A. Sloan, S. C. Smith, Jr., D. T. Anbe, F. G. Kushner, J. P. Ornato, A. K. Jacobs, C. D. Adams, J. L. Anderson, C. E. Buller, M. A. Creager, S. M. Ettinger, J. L. Halperin, S. A. Hunt, B. W. Lytle, R. Nishimura, R. L. Page, B. Riegel, L. G. Tarkington and C. W. Yancy: 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With STElevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 117(2), 296-329 (2008)
13. H. Adams, R. Adams, G. Del Zoppo and L. B. Goldstein: Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 36(4), 916-923 (2005)
14. G. D. Van Olden, J. D. Meeuwis, H. W. Bolhuis, H. Boxma and R. J. Goris: Clinical impact of advanced trauma life support. Am J Emerg Med 22(7), 522-525 (2004) (Pubitemid 40143229)
15. G. D. De La Rosa, M. L. Valencia, C. M. Arango, C. I. Gomez, A. Garcia, S. Ospina, S. Osorno, A. Henao and F. A. Jaimes: Toward an operative diagnosis in sepsis: a latent class approach. BMC Infect Dis 8, 18 (2008)
16. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20(6), 864-874 (1992)
17. M. M. Levy, M. P. Fink, J. C. Marshall, E. Abraham, D. Angus, D. Cook, J. Cohen, S. M. Opal, J. L. Vincent and G. Ramsay: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31(4), 1250-1256 (2003) (Pubitemid 36444440)
18. J. C. Marshall, J. L. Vincent, M. P. Fink, D. J. Cook, G. Rubenfeld, D. Foster, C. J. Fisher, Jr., E. Faist and K. Reinhart: Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med 31(5), 1560-1567 (2003) (Pubitemid 36583875)
19. R. R. Schumann, C. J. Kirschning, A. Unbehaun, H. P. Aberle, H. P. Knope, N. Lamping, R. J. Ulevitch and F. Herrmann: The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol 16(7), 3490-3503 (1996) (Pubitemid 26199868)
20. E. S. Van Amersfoort, T. J. Van Berkel and J. Kuiper: Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 16(3), 379-414 (2003) (Pubitemid 36871313)
21. N. W. Schroder and R. R. Schumann: Non-LPS targets and actions of LPS binding protein (LBP). J Endotoxin Res 11(4), 237-242 (2005) (Pubitemid 41358859)
22. J. A. Russell: Management of sepsis. N Engl J Med 355(16), 1699-1713 (2006) (Pubitemid 44583960)
23. F. A. Bozza, P. T. Bozza and H. C. Castro Faria Neto: Beyond sepsis pathophysiology with cytokines: what is their value as biomarkers for disease severity? Mem Inst Oswaldo Cruz 100 Suppl 1, 217-221 (2005) (Pubitemid 40685467)
24. C. E. Ventetuolo and M. M. Levy: Biomarkers: diagnosis and risk assessment in sepsis. Clin Chest Med 29(4), 591-603, vii (2008)
25. W. S. Tillett and T. Francis Jr.: Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Clin Invest 52, 561-584 (1930)
26. M. B. Pepys and G. M. Hirschfield: C-reactive protein: a critical update. J Clin Invest 111(12), 1805-1812 (2003) (Pubitemid 38057722)
27. S. Black, I. Kushner and D. Samols: C-reactive Protein. J Biol Chem 279(47), 48487-48490 (2004) (Pubitemid 39625721)
28. D. M. Vigushin, M. B. Pepys and P. N. Hawkins: Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 91(4), 1351-1357 (1993) (Pubitemid 23127332)
29. R. Claeys, S. Vinken, H. Spapen, K. Ver Elst, K. Decochez, L. Huyghens and F. K. Gorus: Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 30(4), 757-762 (2002) (Pubitemid 34297790)
30. F. M. Brunkhorst, U. Heinz and Z. F. Forycki: Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 24(8), 888-889 (1998)
31. S. Rinaldi, C. Adembri, S. Grechi and A. R. De Gaudio: Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med 34(9), 2334-2339 (2006) (Pubitemid 44260017)
32. B. Muller, G. Peri, A. Doni, A. P. Perruchoud, R. Landmann, F. Pasqualini and A. Mantovani: High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leukoc Biol 72(4), 643-649 (2002) (Pubitemid 36277834)
33. M. Korppi and L. Kroger: C-reactive protein in viral and bacterial respiratory infection in children. Scand J Infect Dis 25(2), 207-213 (1993) (Pubitemid 23149009)
34. S. G. Lala, S. A. Madhi and J. M. Pettifor: The discriminative value of C-reactive protein levels in distinguishing between community-acquired bacteraemic and respiratory virus-associated lower respiratory tract infections in HIV-1-infected and -uninfected children. Ann Trop Paediatr 22(3), 271-279 (2002)
35. T. Heiskanen-Kosma and M. Korppi: Serum C-reactive protein cannot differentiate bacterial and viral aetiology of community-acquired pneumonia in children in primary healthcare settings. Scand J Infect Dis 32(4), 399-402 (2000) (Pubitemid 30612155)
36. G. P. Castelli, C. Pognani, M. Meisner, A. Stuani, D. Bellomi and L. Sgarbi: Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 8(4), R234-242 (2004)
37. P. Povoa, E. Almeida, P. Moreira, A. Fernandes, R. Mealha, A. Aragao and H. Sabino: C-reactive protein as an indicator of sepsis. Intensive Care Med 24(10), 1052-1056 (1998) (Pubitemid 28497823)
38. A. Luzzani, E. Polati, R. Dorizzi, A. Rungatscher, R. Pavan and A. Merlini: Comparison of procalcitonin and Creactive protein as markers of sepsis. Crit Care Med 31(6), 1737-1741 (2003) (Pubitemid 36714230)
39. J. Silvestre, P. Povoa, L. Coelho, E. Almeida, P. Moreira, A. Fernandes, R. Mealha and H. Sabino: Is Creactive protein a good prognostic marker in septic patients? Intensive Care Med 35(5), 909-913 (2009)
40. F. M. Brunkhorst, K. Wegscheider, Z. F. Forycki and R. Brunkhorst: Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 26 Suppl 2, S148-152 (2000) (Pubitemid 30186573)
41. S. Harbarth, K. Holeckova, C. Froidevaux, D. Pittet, B. Ricou, G. E. Grau, L. Vadas and J. Pugin: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164(3), 396-402 (2001) (Pubitemid 32778205)
42. J. F. Benoist, O. Mimoz and M. Assicot: [Procalcitonin in severe trauma]. Ann Biol Clin (Paris) 56(5), 571-574 (1998) (Pubitemid 28474556)
43. G. P. Castelli, C. Pognani, M. Cita and R. Paladini: Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med 37(6), 1845-1849 (2009)
44. S. M. Lobo, F. R. Lobo, D. P. Bota, F. Lopes-Ferreira, H. M. Soliman, C. Melot and J. L. Vincent: C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 123(6), 2043-2049 (2003) (Pubitemid 36706731)
45. V. Pettila, M. Hynninen, O. Takkunen, P. Kuusela and M. Valtonen: Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 28(9), 1220-1225 (2002) (Pubitemid 35025038)
46. C. Clec'h, F. Ferriere, P. Karoubi, J. P. Fosse, M. Cupa, P. Hoang and Y. Cohen: Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 32(5), 1166-1169 (2004) (Pubitemid 38620986)
47. M. Meisner, K. Tschaikowsky, T. Palmaers and J. Schmidt: Comparison of procalcitonin (PCT) and Creactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 3(1), 45-50 (1999) (Pubitemid 29304058)
48. C. Clec'h, J. P. Fosse, P. Karoubi, F. Vincent, I. Chouahi, L. Hamza, M. Cupa and Y. Cohen: Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 34(1), 102-107 (2006) (Pubitemid 43032386)
49. P. Schuetz, M. Christ-Crain and B. Muller: Biomarkers to improve diagnostic and prognostic accuracy in systemic infections. Curr Opin Crit Care 13(5), 578-585 (2007) (Pubitemid 47357461)
50. E. S. Nylen, A. Al Arifi, K. L. Becker, R. H. Snider, Jr. and A. Alzeer: Effect of classic heatstroke on serum procalcitonin. Crit Care Med 25(8), 1362-1365 (1997) (Pubitemid 27347301)
51. G. A. Wanner, M. Keel, U. Steckholzer, W. Beier, R. Stocker and W. Ertel: Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 28(4), 950-957 (2000) (Pubitemid 30262061)
52. I. De Werra, C. Jaccard, S. B. Corradin, R. Chiolero, B. Yersin, H. Gallati, M. Assicot, C. Bohuon, J. D. Baumgartner, M. P. Glauser and D. Heumann: Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25(4), 607-613 (1997) (Pubitemid 27193972)
53. M. Meisner, K. Tschaikowsky, A. Hutzler, C. Schick and J. Schuttler: Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24(7), 680-684 (1998) (Pubitemid 28393399)
54. A. A. Dahaba, P. H. Rehak and W. F. List: Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 29(4), 579-583 (2003) (Pubitemid 36523674)
55. K. L. Becker, R. Snider and E. S. Nylen: Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 36(3), 941-952 (2008)
56. M. Meisner: Procalcitonin. Thieme, Stuttgart, Germany (2000)
57. P. Dandona, D. Nix, M. F. Wilson, A. Aljada, J. Love, M. Assicot and C. Bohuon: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79(6), 1605-1608 (1994)
58. F. Weis, A. Beiras-Fernandez, G. Schelling, J. Briegel, P. Lang, D. Hauer, S. Kreth, I. Kaufmann, P. Lamm and E. Kilger: Stress doses of hydrocortisone in high-risk patients undergoing cardiac surgery: effects on interleukin-6 to interleukin-10 ratio and early outcome. Crit Care Med 37(5), 1685-1690 (2009)
59. A. A. Dahaba, G. A. Elawady, P. H. Rehak and W. F. List: Procalcitonin and proinflammatory cytokine clearance during continuous venovenous haemofiltration in septic patients. Anaesth Intensive Care 30(3), 269-274 (2002) (Pubitemid 34619015)
60. L. Simon, F. Gauvin, D. K. Amre, P. Saint-Louis and J. Lacroix: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and metaanalysis. Clin Infect Dis 39(2), 206-217 (2004) (Pubitemid 38971491)
61. R. P. Dellinger, M. M. Levy, J. M. Carlet, J. Bion, M. M. Parker, R. Jaeschke, K. Reinhart, D. C. Angus, C. Brun-Buisson, R. Beale, T. Calandra, J. F. Dhainaut, H. Gerlach, M. Harvey, J. J. Marini, J. Marshall, M. Ranieri, G. Ramsay, J. Sevransky, B. T. Thompson, S. Townsend, J. S. Vender, J. L. Zimmerman and J. L. Vincent: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36(1), 296-327 (2008)
62. B. Muller, K. L. Becker, H. Schachinger, P. R. Rickenbacher, P. R. Huber, W. Zimmerli and R. Ritz: Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28(4), 977-983 (2000) (Pubitemid 30262065)
63. K. Reinhart, F. Brunkhorst, H. Bone, H. Gerlach, M. Grundling, G. Kreymann, P. Kujath, G. Marggraf, K. Mayer, A. Meier-Hellmann, C. Peckelsen, C. Putensen, M. Quintel, M. Ragaller, R. Rossaint, F. Stuber, N. Weiler, T. Welte and K. Werdan: [Diagnosis and therapy of sepsis. Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine]. Anaesthesist 55(1), 43-56 (2006)
64. M. Lindberg, A. Hole, H. Johnsen, A. Asberg, A. Rydning, H. E. Myrvold and K. S. Bjerve: Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery. Scand J Clin Lab Invest 62(3), 189-194 (2002) (Pubitemid 34596669)
65. D. Mokart, M. Merlin, A. Sannini, J. P. Brun, J. R. Delpero, G. Houvenaeghel, V. Moutardier and J. L. Blache: Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 94(6), 767-773 (2005) (Pubitemid 40753992)
66. J. T. Macfarlane, A. Colville, A. Guion, R. M. Macfarlane and D. H. Rose: Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet 341(8844), 511-514 (1993) (Pubitemid 23066084)
67. P. Schuetz, M. Christ-Crain and B. Muller: Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections-hope for hype? Swiss Med Wkly 139(23-24), 318-326 (2009)
68. M. Christ-Crain, D. Stolz, R. Bingisser, C. Muller, D. Miedinger, P. R. Huber, W. Zimmerli, S. Harbarth, M. Tamm and B. Muller: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174(1), 84-93 (2006) (Pubitemid 43955248)
69. M. Christ-Crain, D. Jaccard-Stolz, R. Bingisser, M. M. Gencay, P. R. Huber, M. Tamm and B. Muller: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363(9409), 600-607 (2004) (Pubitemid 38264177)
70. V. Nobre, S. Harbarth, J. D. Graf, P. Rohner and J. Pugin: Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 177(5), 498-505 (2008) (Pubitemid 351442188)
71. A. A. Dahaba, B. Hagara, A. Fall, P. H. Rehak, W. F. List and H. Metzler: Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 97(4), 503-508 (2006) (Pubitemid 44419965)
72. J. U. Jensen, L. Heslet, T. H. Jensen, K. Espersen, P. Steffensen and M. Tvede: Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34(10), 2596-2602 (2006) (Pubitemid 44413058)
73. B. Uzzan, R. Cohen, P. Nicolas, M. Cucherat and G. Y. Perret: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34(7), 1996-2003 (2006) (Pubitemid 43982479)
74. B. M. Tang, G. D. Eslick, J. C. Craig and A. S. McLean: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7(3), 210-217 (2007) (Pubitemid 46274517)
75. K. Reinhart and F. M. Brunkhorst: Meta-analysis of procalcitonin for sepsis detection. Lancet Infect Dis 7(8), 500-502; author reply 502-503 (2007) (Pubitemid 47077709)
76. J. U. Jensen, B. Lundgren and J. D. Lundgren: Metaanalysis of procalcitonin for sepsis detection. Lancet Infect Dis 7(8), 499-500; author reply 502-493 (2007)
77. B. Muller, M. Christ-Crain and P. Schuetz: Metaanalysis of procalcitonin for sepsis detection. Lancet Infect Dis 7(8), 498-499; author reply 502-493 (2007)
78. M. Song and J. A. Kellum: Interleukin-6. Crit Care Med 33(12 Suppl), S463-465 (2005) (Pubitemid 41785989)
79. B. M. Woloski, E. M. Smith, W. J. Meyer, 3rd, G. M. Fuller and J. E. Blalock: Corticotropin-releasing activity of monokines. Science 230(4729), 1035-1037 (1985) (Pubitemid 16192689)
80. S. Gaini, O. G. Koldkjaer, C. Pedersen and S. S. Pedersen: Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in communityacquired infections and sepsis: a prospective study. Crit Care 10(2), R53 (2006)
81. Y. Fong, L. L. Moldawer, M. Marano, H. Wei, S. B. Tatter, R. H. Clarick, U. Santhanam, D. Sherris, L. T. May, P. B. Sehgal and Et al.: Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man. J Immunol 142(7), 2321-2324 (1989) (Pubitemid 19098241)
82. P. Fraunberger, Y. Wang, E. Holler, K. G. Parhofer, D. Nagel, A. K. Walli and D. Seidel: Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock 26(1), 10-12 (2006) (Pubitemid 44296999)
83. E. A. Panacek, J. C. Marshall, T. E. Albertson, D. H. Johnson, S. Johnson, R. D. Macarthur, M. Miller, W. T. Barchuk, S. Fischkoff, M. Kaul, L. Teoh, L. Van Meter, L. Daum, S. Lemeshow, G. Hicklin and C. Doig: Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F (ab') 2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 32(11), 2173-2182 (2004) (Pubitemid 39491795)
84. C. A. Gogos, E. Drosou, H. P. Bassaris and A. Skoutelis: Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181(1), 176-180 (2000) (Pubitemid 30049046)
85. L. C. Casey, R. A. Balk and R. C. Bone: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119(8), 771-778 (1993) (Pubitemid 24012641)
86. C. H. Wakefield, G. R. Barclay, K. C. Fearon, A. S. Goldie, J. A. Ross, I. S. Grant, G. Ramsay and J. C. Howie: Proinflammatory mediator activity, endogenous antagonists and the systemic inflammatory response in intra-abdominal sepsis. Scottish Sepsis Intervention Group. Br J Surg 85(6), 818-825 (1998) (Pubitemid 28300517)
87. W. J. Kox, T. Volk, S. N. Kox and H. D. Volk: Immunomodulatory therapies in sepsis. Intensive Care Med 26 Suppl 1, S124-128 (2000) (Pubitemid 30184503)
88. E. Watanabe, H. Hirasawa, S. Oda, K. Matsuda, M. Hatano and T. Tokuhisa: Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor-and interleukin-1-related gene polymorphisms. Crit Care Med 33(1), 89-97; discussion 242-243 (2005) (Pubitemid 40116541)
89. H. Tanaka, K. Ishikawa, M. Nishino, T. Shimazu and T. Yoshioka: Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis. J Trauma 40(5), 718-725; discussion 725-716 (1996) (Pubitemid 126425021)
90. M. R. Pinsky, J. L. Vincent, J. Deviere, M. Alegre, R. J. Kahn and E. Dupont: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103(2), 565-575 (1993) (Pubitemid 23070764)
91. C. Wunder, O. Eichelbronner and N. Roewer: Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res 53(4), 158-163 (2004) (Pubitemid 38526599)
92. N. Aikawa, S. Fujishima, S. Endo, I. Sekine, K. Kogawa, Y. Yamamoto, S. Kushimoto, H. Yukioka, N. Kato, K. Totsuka, K. Kikuchi, T. Ikeda, K. Ikeda, K. Harada and S. Satomura: Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 11(3), 152-159 (2005) (Pubitemid 40933683)
93. P. S. Tobias, K. Soldau and R. J. Ulevitch: Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 164(3), 777-793 (1986) (Pubitemid 16024834)
94. M. J. Fenton and D. T. Golenbock: LPS-binding proteins and receptors. J Leukoc Biol 64(1), 25-32 (1998) (Pubitemid 28304670)
95. R. R. Schumann and J. Zweigner: A novel acute-phase marker: lipopolysaccharide binding protein (LBP). Clin Chem Lab Med 37(3), 271-274 (1999) (Pubitemid 29209740)
96. P. A. Thompson, P. S. Tobias, S. Viriyakosol, T. N. Kirkland and R. L. Kitchens: Lipopolysaccharide (LPS) - binding protein inhibits responses to cell-bound LPS. J Biol Chem 278(31), 28367-28371 (2003) (Pubitemid 36935736)
97. A. Sablotzki, J. Borgermann, W. Baulig, I. Friedrich, J. Spillner, R. E. Silber and E. Czeslick: Lipopolysaccharidebinding protein (LBP) and markers of acute-phase response in patients with multiple organ dysfunction syndrome (MODS) following open heart surgery. Thorac Cardiovasc Surg 49(5), 273-278 (2001) (Pubitemid 33041572)
98. A. Myc, J. Buck, J. Gonin, B. Reynolds, U. Hammerling and D. Emanuel: The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome. Clin Diagn Lab Immunol 4(2), 113-116 (1997) (Pubitemid 27130220)
99. B. Rau, G. Steinbach, C. M. Kruger, K. Baumgart, M. Schilling and H. G. Beger: Clinical value of lipopolysaccharide-binding protein (LBP) determinations in acute pancreatitis. Langenbecks Arch Surg 388(3), 181-188 (2003) (Pubitemid 36987709)
100. S. C. Cunningham, D. L. Malone, G. V. Bochicchio, T. Genuit, K. Keledjian, J. K. Tracy and L. M. Napolitano: Serum lipopolysaccharide-binding protein concentrations in trauma victims. Surg Infect (Larchmt) 7(3), 251-261 (2006) (Pubitemid 44193613)
101. L. Blairon, X. Wittebole and P. F. Laterre: Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections. J Infect Dis 187(2), 287-291 (2003) (Pubitemid 36132642)
102. P. S. Tobias, J. Mathison, D. Mintz, J. D. Lee, V. Kravchenko, K. Kato, J. Pugin and R. J. Ulevitch: Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation. Am J Respir Cell Mol Biol 7(3), 239-245 (1992)
103. C. S. Oude Nijhuis, E. Vellenga, S. M. Daenen, W. T. Van der Graaf, J. A. Gietema, H. J. Groen, W. A. Kamps and E. S. De Bont: Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients. Intensive Care Med 29(12), 2157-2161 (2003) (Pubitemid 38030665)
104. Y. Sakr, U. Burgett, F. E. Nacul, K. Reinhart and F. Brunkhorst: Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis? Crit Care Med 36(7), 2014-2022 (2008)
105. M. Prucha, I. Herold, R. Zazula, L. Dubska, M. Dostal, T. Hildebrand and J. Hyanek: Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patients. Crit Care 7(6), R154-159 (2003)
106. A. H. Froon, M. A. Dentener, J. W. Greve, G. Ramsay and W. A. Buurman: Lipopolysaccharide toxicity-regulating proteins in bacteremia. J Infect Dis 171(5), 1250-1257 (1995)
107. A. Albillos, A. De-La-Hera and M. Alvarez-Mon: Serum lipopolysaccharide- binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet 363(9421), 1608-1610 (2004) (Pubitemid 38625665)
108. S. M. Opal, P. J. Scannon, J. L. Vincent, M. White, S. F. Carroll, J. E. Palardy, N. A. Parejo, J. P. Pribble and J. H. Lemke: Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180(5), 1584-1589 (1999) (Pubitemid 29506461)
109. K. M. Ubenauf, M. Krueger, P. Henneke and R. Berner: Lipopolysaccharide binding protein is a potential marker for invasive bacterial infections in children. Pediatr Infect Dis J 26(2), 159-162 (2007) (Pubitemid 46183367)
110. M. Pavcnik-Arnol, S. Hojker and M. Derganc: Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intensive Care Med 30(7), 1454-1460 (2004) (Pubitemid 38951731)
111. M. Pavcnik-Arnol, S. Hojker and M. Derganc: Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children. Intensive Care Med 33(6), 1025-1032 (2007) (Pubitemid 46835415)
112. T. W. Orlikowsky, C. Trug, F. Neunhoeffer, M. Deperschmidt, M. Eichner and C. F. Poets: Lipopolysaccharide-binding protein in noninfected neonates and those with suspected early-onset bacterial infection. J Perinatol 26(2), 115-119 (2006)
113. P. C. Ng, S. H. Cheng, K. M. Chui, T. F. Fok, M. Y. Wong, W. Wong, R. P. Wong and K. L. Cheung: Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 77(3), F221-227 (1997) (Pubitemid 28201589)
114. K. Bell, M. Wattie, K. Byth, R. Silvestrini, P. Clark, E. Stachowski and E. M. Benson: Procalcitonin: a marker of bacteraemia in SIRS. Anaesth Intensive Care 31(6), 629-636 (2003)
115. K. Kofoed, O. Andersen, G. Kronborg, M. Tvede, J. Petersen, J. Eugen-Olsen and K. Larsen: Use of plasma Creactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 11(2), R38 (2007)
116. J. Phua, E. S. Koay and K. H. Lee: Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 29(3), 328-333 (2008) (Pubitemid 351271703)
117. N. I. Shapiro, S. Trzeciak, J. E. Hollander, R. Birkhahn, R. Otero, T. M. Osborn, E. Moretti, H. B. Nguyen, K. J. Gunnerson, D. Milzman, D. F. Gaieski, M. Goyal, C. B. Cairns, L. Ngo and E. P. Rivers: A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 37(1), 96-104 (2009)
118. J. S. Brauner, L. E. Rohde and N. Clausell: Circulating endothelin-1 and tumor necrosis factor-alpha: early predictors of mortality in patients with septic shock. Intensive Care Med 26(3), 305-313 (2000) (Pubitemid 30209511)
119. D. Torre, R. Tambini, M. Manfredi, V. Mangani, P. Livi, V. Maldifassi, P. Campi and F. Speranza: Circulating levels of FAS/APO-1 in patients with the systemic inflammatory response syndrome. Diagn Microbiol Infect Dis 45(4), 233-236 (2003) (Pubitemid 36555671)
120. N. Chopin, B. Floccard, F. Sobas, J. Illinger, E. Boselli, F. Benatir, A. Levrat, C. Guillaume, J. Crozon, C. Negrier and B. Allaouchiche: Activated partial thromboplastin time waveform analysis: a new tool to detect infection? Crit Care Med 34(6), 1654-1660 (2006) (Pubitemid 43810044)
121. H. R. Wong, N. Cvijanovich, D. S. Wheeler, M. T. Bigham, M. Monaco, K. Odoms, W. L. Macias and M. D. Williams: Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med 178(3), 276-282 (2008)
122. J. J. Saenz, J. J. Izura, A. Manrique, F. Sala and I. Gaminde: Early prognosis in severe sepsis via analyzing the monocyte immunophenotype. Intensive Care Med 27(6), 970-977 (2001) (Pubitemid 32662477)
123. A. Blanco, G. Solis, E. Arranz, G. D. Coto, A. Ramos and J. Telleria: Serum levels of CD14 in neonatal sepsis by Gram-positive and Gram-negative bacteria. Acta Paediatr 85(6), 728-732 (1996) (Pubitemid 26262555)
124. B. Dahl, F. V. Schiodt, P. Ott, F. Wians, W. M. Lee, J. Balko and G. E. O'keefe: Plasma concentration of Gcglobulin is associated with organ dysfunction and sepsis after injury. Crit Care Med 31(1), 152-156 (2003) (Pubitemid 36151165)
125. B. Muller, G. Peri, A. Doni, V. Torri, R. Landmann, B. Bottazzi and A. Mantovani: Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 29(7), 1404-1407 (2001) (Pubitemid 32641804)
126. I. De Freitas, M. Fernandez-Somoza, E. Essenfeld-Sekler and J. E. Cardier: Serum levels of the apoptosis-associated molecules, tumor necrosis factor-alpha/tumor necrosis factor type-I receptor and Fas/FasL, in sepsis. Chest 125(6), 2238-2246 (2004) (Pubitemid 38788195)
127. V. Pettila, J. Pentti, M. Pettila, O. Takkunen and I. Jousela: Predictive value of antithrombin III and serum Creactive protein concentration in critically ill patients with suspected sepsis. Crit Care Med 30(2), 271-275 (2002) (Pubitemid 34158106)
128. A. Lekkou, M. Karakantza, A. Mouzaki, F. Kalfarentzos and C. A. Gogos: Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 11(1), 161-167 (2004) (Pubitemid 38090671)
129. J. J. Hoffmann: Neutrophil CD64: a diagnostic marker for infection and sepsis. Clin Chem Lab Med 47(8), 903-916 (2009)
130. Y. Yaegashi, K. Shirakawa, N. Sato, Y. Suzuki, M. Kojika, S. Imai, G. Takahashi, M. Miyata, S. Furusako and S. Endo: Evaluation of a newly identified
131. J. Y. Chien, J. S. Jerng, C. J. Yu and P. C. Yang: Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 33(8), 1688-1693 (2005)
132. D. Borgel, S. Clauser, C. Bornstain, I. Bieche, A. Bissery, V. Remones, J. Y. Fagon, M. Aiach and J. L. Diehl: Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med 34(1), 219-222 (2006) (Pubitemid 43032400)
133. S. Madoiwa, S. Nunomiya, T. Ono, Y. Shintani, T. Ohmori, J. Mimuro and Y. Sakata: Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation. Int J Hematol 84(5), 398-405 (2006) (Pubitemid 46052628)
134. A. R. Novotny, K. Emmanuel, K. Ulm, H. Bartels, J. R. Siewert, H. Weighardt and B. Holzmann: Blood interleukin 12 as preoperative predictor of fatal postoperative sepsis after neoadjuvant radiochemotherapy. Br J Surg 93(10), 1283-1289 (2006) (Pubitemid 44547030)
135. W. Oczenski, H. Krenn, R. Jilch, H. Watzka, F. Waldenberger, U. Koller, S. Schwarz and R. D. Fitzgerald: HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med 29(8), 1253-1257 (2003) (Pubitemid 37041152)
136. H. J. Moller, S. K. Moestrup, N. Weis, C. Wejse, H. Nielsen, S. S. Pedersen, J. Attermann, E. Nexo and G. Kronborg: Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163. Crit Care Med 34(10), 2561-2566 (2006) (Pubitemid 44413053)
137. G. Monneret, N. Voirin, I. Krawice-Radanne, J. Bohe, A. Lepape, N. Rouas-Freiss and E. D. Carosella: Soluble human leukocyte antigen-G5 in septic shock: marked and persisting elevation as a predictor of survival. Crit Care Med 35(8), 1942-1947 (2007) (Pubitemid 47220370)
138. J. Schroder, F. Stuber, H. Gallati, F. U. Schade and B. Kremer: Pattern of soluble TNF receptors I and II in sepsis. Infection 23(3), 143-148 (1995)
139. M. A. Weigand, H. Schmidt, M. Pourmahmoud, Q. Zhao, E. Martin and H. J. Bardenheuer: Circulating intercellular adhesion molecule-1 as an early predictor of hepatic failure in patients with septic shock. Crit Care Med 27(12), 2656-2661 (1999) (Pubitemid 30027176)
140. S. G. Zakynthinos, S. Papanikolaou, T. Theodoridis, E. G. Zakynthinos, V. Christopoulou-Kokkinou, G. Katsaris and A. C. Mavrommatis: Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients. Crit Care Med 32(4), 1004-1010 (2004) (Pubitemid 38471523)
141. M. Siassi, J. Riese, R. Steffensen, M. Meisner, S. Thiel, W. Hohenberger and J. Schmidt: Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. Crit Care 9(5), R483-489 (2005)
142. L. B. Ware, M. D. Eisner, B. T. Thompson, P. E. Parsons and M. A. Matthay: Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 170(7), 766-772 (2004) (Pubitemid 39298992)
143. G. Pilz, P. Fraunberger, R. Appel, E. Kreuzer, K. Werdan, A. Walli and D. Seidel: Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations. Crit Care Med 24(4), 596-600 (1996) (Pubitemid 26133792)
144. S. Gibot, M. N. Kolopp-Sarda, M. C. Bene, A. Cravoisy, B. Levy, G. C. Faure and P. E. Bollaert: Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 141(1), 9-15 (2004)
145. M. Varpula, K. Pulkki, S. Karlsson, E. Ruokonen and V. Pettila: Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Crit Care Med 35(5), 1277-1283 (2007) (Pubitemid 46642654)
146. M. Christ-Crain, N. G. Morgenthaler, J. Struck, S. Harbarth, A. Bergmann and B. Muller: Mid-regional proadrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 9(6), R816-824 (2005)
147. S. E. Orfanos, A. Kotanidou, C. Glynos, C. Athanasiou, S. Tsigkos, I. Dimopoulou, C. Sotiropoulou, S. Zakynthinos, A. Armaganidis, A. Papapetropoulos and C. Roussos: Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 35(1), 199-206 (2007) (Pubitemid 46035696)
148. M. Cetinkaya, H. Ozkan, N. Koksal, S. Celebi and M. Hacimustafaoglu: Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. J Perinatol 29(3), 225-231 (2009)
149. B. Al-Nawas, I. Krammer and P. M. Shah: Procalcitonin in diagnosis of severe infections. Eur J Med Res 1(7), 331-333 (1996)
150. R. Arkader, E. J. Troster, M. R. Lopes, R. R. Junior, J. A. Carcillo, C. Leone and T. S. Okay: Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch Dis Child 91(2), 117-120 (2006) (Pubitemid 43372019)
151. A. Aouifi, V. Piriou, O. Bastien, P. Blanc, H. Bouvier, R. Evans, M. Celard, F. Vandenesch, R. Rousson and J. J. Lehot: Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 28(9), 3171-3176 (2000)
152. I. C. Balc, H. Sungurtekin, E. Gurses, U. Sungurtekin and B. Kaptanoglu: Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 7(1), 85-90 (2003) (Pubitemid 36204274)
153. A. W. Bossink, A. B. Groeneveld and L. G. Thijs: Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastasealpha1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis 29(2), 398-407 (1999) (Pubitemid 29380207)
154. G. P. Castelli, C. Pognani, M. Cita, A. Stuani, L. Sgarbi and R. Paladini: Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol 72(1-2), 69-80 (2006) (Pubitemid 43230810)
155. Y. L. Chan, C. P. Tseng, P. K. Tsay, S. S. Chang, T. F. Chiu and J. C. Chen: Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care 8(1), R12-20 (2004)
156. C. Cheval, J. F. Timsit, M. Garrouste-Orgeas, M. Assicot, B. De Jonghe, B. Misset, C. Bohuon and J. Carlet: Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients. Intensive Care Med 26 Suppl 2, S153-158 (2000) (Pubitemid 30186574)
157. H. Dorge, F. A. Schondube, P. Dorge, R. Seipelt, M. Voss and B. J. Messmer: Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection. Thorac Cardiovasc Surg 51(6), 322-326 (2003) (Pubitemid 38031388)
158. B. Du, J. Pan, D. Chen and Y. Li: Serum procalcitonin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and non-infectious origin. Chin Med J (Engl) 116(4), 538-542 (2003) (Pubitemid 36675853)
159. S. Endo, N. Aikawa, S. Fujishima, I. Sekine, K. Kogawa, Y. Yamamoto, S. Kushimoto, H. Yukioka, N. Kato, K. Totsuka, K. Kikuchi, T. Ikeda, K. Ikeda, H. Yamada, K. Harada and S. Satomura: Usefulness of procalcitonin serum level for the discrimination of severe sepsis from sepsis: a multicenter prospective study. J Infect Chemother 14(3), 244-249 (2008) (Pubitemid 351875922)
160. A. Enguix, C. Rey, A. Concha, A. Medina, D. Coto and M. A. Dieguez: Comparison of procalcitonin with Creactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 27(1), 211-215 (2001) (Pubitemid 32208990)
161. A. Geppert, A. Steiner, G. Delle-Karth, G. Heinz and K. Huber: Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med 29(8), 1384-1389 (2003) (Pubitemid 37041172)
162. E. J. Giamarellos-Bourboulis, A. Mega, P. Grecka, N. Scarpa, G. Koratzanis, G. Thomopoulos and H. Giamarellou: Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 28(9), 1351-1356 (2002) (Pubitemid 35025058)
163. P. Hausfater, S. Garric, S. B. Ayed, M. Rosenheim, M. Bernard and B. Riou: Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis 34(7), 895-901 (2002) (Pubitemid 34229756)
164. M. Meisner, C. Rauschmayer, J. Schmidt, R. Feyrer, R. Cesnjevar, D. Bredle and K. Tschaikowsky: Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med 28(8), 1094-1102 (2002) (Pubitemid 34985233)
165. B. Resch, W. Gusenleitner and W. D. Muller: Procalcitonin and interleukin-6 in the diagnosis of earlyonset sepsis of the neonate. Acta Paediatr 92(2), 243-245 (2003) (Pubitemid 36390432)
166. E. Ruokonen, L. Ilkka, M. Niskanen and J. Takala: Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 46(4), 398-404 (2002) (Pubitemid 34454435)
167. O. Selberg, H. Hecker, M. Martin, A. Klos, W. Bautsch and J. Kohl: Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 28(8), 2793-2798 (2000)
168. G. R. Stryjewski, E. S. Nylen, M. J. Bell, R. H. Snider, K. L. Becker, A. Wu, C. Lawlor and H. Dalton: Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med 6(2), 129-135 (2005) (Pubitemid 40724303)
169. E. Suprin, C. Camus, A. Gacouin, Y. Le Tulzo, S. Lavoue, A. Feuillu and R. Thomas: Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med 26(9), 1232-1238 (2000)
170. S. Tugrul, F. Esen, S. Celebi, P. E. Ozcan, O. Akinci, N. Cakar and L. Telci: Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response. Anaesth Intensive Care 30(6), 747-754 (2002) (Pubitemid 35469711)
171. H. Ugarte, E. Silva, D. Mercan, A. De Mendonca and J. L. Vincent: Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27(3), 498-504 (1999) (Pubitemid 29162669)
172. Whang K.T.,Steinwald P.M.,White J.C.,Nylen E.S.,Snider R.H.,Simon G.L.,Goldberg R.L.,Becker K.L.,Serum calcitonin precursors in sepsis and systemic inflammation 1998,83,9,3296-3301,DOI 10.1210/jc.83.9.3296